TOP STORIES

• BUSINESS Kyowa Kirin Looks to Make Crysvita 1st In-House Blockbuster, Sees 100 Billion Yen Target “Not Unachievable”
  June 5, 2020

• ORGANIZATION API/Intermediate Imports from India Still Stalled, Traders’ Group Calls for Govt Schemes
  June 4, 2020

• BUSINESS Kyowa Hakko Bio’s GMP Breach Triggers Shipment Curbs, Stockouts at Astellas, Kowa; Impact Could Reverberate Further
  June 3, 2020

• BUSINESS 15 Drug Makers See 3.6% Negative Growth in Japan in FY2020 as Re-Pricing, Generic Entries Weigh: Jiho Tally
  June 2, 2020

• BUSINESS 6 Japan Drug Makers Net 20% Growth in China Biz Despite COVID-19 Woes
  June 1, 2020

• REGULATORY Oral Semaglutide Clears MHLW Panel, Now in Line for June Approval
  June 1, 2020

• ACADEMIA Japan to Join NIH’s Remdesivir-Baricitinib Combo Trial for COVID-19
  June 1, 2020

• BUSINESS Sanofi Japan Introduces 2-Week-Rule before Getting Back to Full Operations after COVID-19 Emergency Lift
  May 29, 2020

• ACADEMIA Nagasaki Univ. to Launch Clinical Trial for Nelfinavir for COVID-19
  May 28, 2020

• BUSINESS Drug Makers Exploring “New Normal” in Post-COVID-19; Takeda Plans Major Changes
  May 28, 2020

• BUSINESS Japan SGLT2 Inhibitor Market Hits 100 Billion Yen after Weak Start: Jiho Estimate
  May 27, 2020

• REGULATORY Japan Drops May-End Goal for Avigan’s COVID-19 Approval
  May 27, 2020

• ACADEMIA Discontinued HIV Med Nelfinavir Hits Limelight as Potential COVID-19 Treatment
  May 26, 2020

• REGULATORY MSD’s 9-Valent HPV Vaccine Now in Line for June Approval; Eyes on Its Possible Inclusion in National Immunization Program
  May 25, 2020

• BUSINESS GSK Japan Looking to Develop Otilimab for COVID-19; President Stresses Efforts on Vaccines, Disease Management Too
  May 22, 2020

• ACADEMIA Avigan Interim Analysis Not Intended to Determine Efficacy, Research Sponsor Says on Reports
  May 21, 2020

• REGULATORY MHLW Adds Veklury in Updated COVID-19 Treatment Guide
  May 20, 2020

• BUSINESS Nichi-Iko Launches Another Recall, Now Pulling 8 More APIs/9 Products
  May 19, 2020

• REGULATORY Check Latest Info and Make Careful Decision on Veklury Use: PMDA Review Report
  May 19, 2020

• BUSINESS Many Drug Makers Continue Work-from-Home, Voluntary Visit Bans after Govt Partially Lifts COVID-19 Emergency
  May 18, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 119
• 120
• 121
• 122
• 123
• 124
• 125
• 126
• 127
• …
• Next ›
• 最終 »